High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI
Objective. To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative agent for MRI. We report our institution’s experience. Design. A retrospective institutional review of dexmedetomidine usage for pediatric MRI over 5.5 years. Protocol included a dexmedetomidine bolus of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/2015/397372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567139266985984 |
|---|---|
| author | Sheikh Sohail Ahmed Tamara Unland James E. Slaven Mara E. Nitu |
| author_facet | Sheikh Sohail Ahmed Tamara Unland James E. Slaven Mara E. Nitu |
| author_sort | Sheikh Sohail Ahmed |
| collection | DOAJ |
| description | Objective. To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative agent for MRI. We report our institution’s experience. Design. A retrospective institutional review of dexmedetomidine usage for pediatric MRI over 5.5 years. Protocol included a dexmedetomidine bolus of 2 μg/kg intravenously over ten minutes followed by 1 μg/kg/hr infusion. 544 patients received high dose dexmedetomidine for MRI. A second bolus was used in 103 (18.9%) patients. 117 (21.5%) required additional medications. Efficacy, side effects, and use of additional medicines to complete the MRI were reviewed. Data was analyzed using Student’s t-test, Fisher’s exact test, and Analysis of Variance (ANOVA). Main Results. Dexmedetomidine infusion was associated with bradycardia (3.9%) and hypotension (18.4%). None of the patients required any intervention. Vital signs were not significantly different among the subgroup of patients receiving one or two boluses of dexmedetomidine or additional medications. Procedure time was significantly shorter in the group receiving only one dexmedetomidine bolus and increased with second bolus or additional medications (P<0.0001). Discharge time was longer for children experiencing bradycardia (P=0.0012). Conclusion. High dose Dexmedetomidine was effective in 78.5% of cases; 21.5% of patients required additional medications. Side effects occurred in approximately 25% of cases, resolving spontaneously. |
| format | Article |
| id | doaj-art-ee12286a252049309a9fd9cdcc64dc62 |
| institution | Kabale University |
| issn | 1687-9740 1687-9759 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Pediatrics |
| spelling | doaj-art-ee12286a252049309a9fd9cdcc64dc622025-02-03T01:02:25ZengWileyInternational Journal of Pediatrics1687-97401687-97592015-01-01201510.1155/2015/397372397372High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRISheikh Sohail Ahmed0Tamara Unland1James E. Slaven2Mara E. Nitu3Department of Pediatrics, Section of Pediatric Critical Care, Pediatric Sedation and Cardiovascular Intensive Care Unit, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, 705 Riley Hospital Drive RI 4909 4B, Indianapolis, IN 46202, USADepartment of Pediatrics, Pediatric Procedural Sedation, Riley Hospital for Children at IU Health North, 11700 N. Meridian Street, Carmel, IN 46032, USADepartment of Biostatistics, Indiana University School of Medicine, 410 W. 10th Street, Suite 3000, Indianapolis, IN 46202, USADepartment of Pediatrics, Section of Pediatric Critical Care, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, 705 Riley Hospital Drive RI 4909 4B, Indianapolis, IN 46202, USAObjective. To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative agent for MRI. We report our institution’s experience. Design. A retrospective institutional review of dexmedetomidine usage for pediatric MRI over 5.5 years. Protocol included a dexmedetomidine bolus of 2 μg/kg intravenously over ten minutes followed by 1 μg/kg/hr infusion. 544 patients received high dose dexmedetomidine for MRI. A second bolus was used in 103 (18.9%) patients. 117 (21.5%) required additional medications. Efficacy, side effects, and use of additional medicines to complete the MRI were reviewed. Data was analyzed using Student’s t-test, Fisher’s exact test, and Analysis of Variance (ANOVA). Main Results. Dexmedetomidine infusion was associated with bradycardia (3.9%) and hypotension (18.4%). None of the patients required any intervention. Vital signs were not significantly different among the subgroup of patients receiving one or two boluses of dexmedetomidine or additional medications. Procedure time was significantly shorter in the group receiving only one dexmedetomidine bolus and increased with second bolus or additional medications (P<0.0001). Discharge time was longer for children experiencing bradycardia (P=0.0012). Conclusion. High dose Dexmedetomidine was effective in 78.5% of cases; 21.5% of patients required additional medications. Side effects occurred in approximately 25% of cases, resolving spontaneously.http://dx.doi.org/10.1155/2015/397372 |
| spellingShingle | Sheikh Sohail Ahmed Tamara Unland James E. Slaven Mara E. Nitu High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI International Journal of Pediatrics |
| title | High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI |
| title_full | High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI |
| title_fullStr | High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI |
| title_full_unstemmed | High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI |
| title_short | High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI |
| title_sort | high dose dexmedetomidine effective as a sole agent sedation for children undergoing mri |
| url | http://dx.doi.org/10.1155/2015/397372 |
| work_keys_str_mv | AT sheikhsohailahmed highdosedexmedetomidineeffectiveasasoleagentsedationforchildrenundergoingmri AT tamaraunland highdosedexmedetomidineeffectiveasasoleagentsedationforchildrenundergoingmri AT jameseslaven highdosedexmedetomidineeffectiveasasoleagentsedationforchildrenundergoingmri AT maraenitu highdosedexmedetomidineeffectiveasasoleagentsedationforchildrenundergoingmri |